Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 28 of 56
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

MedPharm to develop new XF-drug formulations

These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti‐microbial resistance (AMR). MedPharm is a world